coronavirusinduc
common
cold
allergeninduc
rhiniti
character
nasal
mucos
exud
bulk
blood
plasma
mucos
exud
process
involv
flood
lamina
propria
plasmaderiv
bind
protein
possibl
subepitheli
inflammatori
cytokin
mediat
may
move
exud
mucos
surfac
studi
analys
cytokin
level
nasal
lavag
nal
fluid
nonallerg
subject
inocul
coronaviru
n
subject
allerg
birch
pollen
rhiniti
subject
addit
allergen
challeng
sampl
obtain
min
post
challeng
laboratori
n
ten
inocul
subject
develop
common
cold
remain
healthi
granulocytemacrophag
colonystimul
factor
gmcsf
analys
unprocess
nal
fluid
use
immunoassay
subject
develop
common
cold
increas
nal
fluid
level
p
correl
well
symptom
p
increas
subject
allerg
rhiniti
level
similar
nal
fluid
obtain
inocul
subject
subject
allerg
rhiniti
nal
fluid
level
gmcsf
increas
p
gmcsf
detect
common
cold
detect
nal
fluid
present
cytokin
may
eman
superfici
mucos
cell
aid
plasma
exud
subepitheli
cytokin
may
potenti
also
retriev
mucos
surfac
studi
provid
origin
vivo
data
support
notion
thi
profil
cytokin
notabl
present
viral
infect
support
view
gmcsf
import
cytokin
allerg
airway
diseas
previous
demonstr
lumin
entri
plasma
includ
larg
bind
protein
flbrinogen
common
cold
allerg
rhiniti
may
bind
transport
varieti
eytokin
mucos
exud
process
preced
extravas
plasma
primari
plasma
exud
flood
lamina
propria
clear
noninjuri
paracellular
epitheli
mechan
airway
lumen
henc
inflammatori
factor
eman
epitheli
subepitheli
airway
cell
may
move
mucos
surfac
particularli
exud
phase
airway
inflamm
inflammatori
respons
infect
allergen
potenti
involv
gener
varieti
cytokin
pleiotrop
cytokin
multipl
effect
seri
immun
hematopoiet
system
major
biolog
activ
granulocytemacrophag
colonystimul
factor
gmcsf
induc
prolifer
differenti
granulocyt
monocyt
stem
cell
appear
essenti
requir
ige
product
wherea
inhibit
effect
possibihti
viral
infect
gener
also
interest
view
effect
cytokin
thelper
th
cell
properti
may
thu
induc
posit
immun
inhibit
develop
depend
allerg
respons
hand
may
increas
mhc
class
ii
express
epitheli
line
cell
potenti
abrog
induc
immun
unrespons
although
numer
studi
cytokin
gener
inflammatori
cell
structur
cell
vitro
littl
known
vivo
appear
cytokin
human
airway
mucosa
inflammatori
airway
diseas
analys
cytokin
appear
nasal
mucos
surfac
plasma
exud
also
known
occur
viral
infect
allerg
diseas
thu
examin
cytokin
profil
nasal
lavag
nal
fluid
obtain
morn
common
cold
allergen
challeng
season
allerg
rhiniti
common
cold
twenti
male
healthi
nonallerg
volunt
year
isol
group
four
day
day
subject
remain
healthi
inocul
tissu
cultur
infect
dose
ie
dose
produc
infect
cultur
human
coronaviru
nose
base
outcom
seri
symptom
clinic
sign
record
accord
bear
reed
subject
could
divid
two
group
common
cold
n
free
common
cold
n
fig
la
detail
clinic
cours
plasma
exud
process
report
elsewher
allerg
rhiniti
ten
patient
nine
male
year
allerg
rhiniti
posit
histori
skinprick
test
birch
pollen
challeng
right
nasal
caviti
first
diluent
sq
unit
birth
pollen
allergen
alk
copenhagen
denmark
end
swedish
birch
pollen
season
diluent
allergen
administ
singl
actuact
lomin
interv
use
spray
devic
nasal
symptom
experienc
min
interv
challeng
record
nasal
itch
blockag
secret
score
mild
moder
sever
symptom
furthermor
number
sneez
count
transform
score
sneez
total
symptom
score
calcul
addit
four
score
fig
ib
subject
gave
written
inform
consent
particip
studi
protocol
approv
ethic
committe
nasal
lavag
nal
carri
aid
compress
nasal
pool
devic
insert
right
nostril
thu
ml
salin
instil
kept
unilater
nasal
caviti
compress
accordion
part
devic
use
techniqu
lavag
fluid
regularli
recov
devic
min
releas
pressur
lavag
fluid
centrifug
min
x
g
cell
free
nal
fluid
store
common
cold
coronaviru
inocul
subject
morn
h
nal
carri
day
prior
day
inocul
allerg
rhiniti
two
quick
lavag
carri
diluent
challeng
clear
nasal
caviti
accumul
nasal
secretionsexud
thereaft
nal
carri
min
challeng
diluent
dose
allergen
sq
unit
cytokin
analys
nal
fluid
recov
diluent
highest
allergen
dose
challeng
cell
free
lavag
supemat
analys
cytokin
use
speciflc
immunoassay
interferongamma
elisa
detect
limit
elisa
r
system
minneapoli
usa
detect
limit
granulocytemacrophag
colonystimul
factor
gmcsf
elisa
genzym
boston
usa
detect
limit
pgml
elisa
r
system
detect
limit
pgml
elisa
genzym
detect
limit
pgml
present
studi
kit
variat
coeffici
repeat
measur
lower
accept
result
group
present
meanisem
individu
valu
comparison
variabl
within
group
perform
use
friedman
test
wilcoxon
sign
rank
test
comparison
group
perform
use
mannwhitney
ftest
correl
test
calcul
spearman
correl
coeflici
differ
consid
signiflc
aip
report
elsewher
half
coronaviru
inocul
subject
develop
symptom
common
cold
half
remain
healthi
fig
la
subject
season
allerg
rhiniti
develop
symptom
challeng
cumul
dose
birch
pollen
allergen
fig
ib
nal
perform
exud
phase
inflamm
caus
either
viru
infect
normal
subject
allergen
challeng
allerg
subject
subject
develop
common
cold
coronaviru
inocul
nal
fluid
level
increas
significantli
day
friedman
test
p
wilcoxon
sign
rank
test
p
compar
day
inocul
mannwhitney
ftest
p
compar
asymptomat
group
day
fig
b
increas
nal
obtain
asymptomat
group
friedman
test
wilcoxon
sign
rank
test
p
subject
allerg
rhiniti
allergen
challeng
caus
signific
chang
nal
fluid
level
fig
level
similar
p
nal
fluid
obtain
symptomat
asymptomat
group
viru
inocul
subject
fig
b
howev
symptomat
group
significantli
higher
day
prior
inocul
friedman
test
p
wilcoxon
sign
rank
test
p
prior
allergen
challeng
detect
pgml
increas
nal
fluid
obtain
allergen
challeng
subject
allerg
rhiniti
wilcoxon
sign
rank
test
p
fig
mean
level
nal
fluid
obtain
exud
phase
allerg
rhiniti
four
time
lower
found
nal
fluid
obtain
exud
phase
common
cold
howev
sinc
level
allerg
rhiniti
group
analys
nal
obtain
repeat
prewash
level
common
cold
group
analys
nal
reflect
basal
level
comparison
absolut
level
lavag
fluid
cytokin
group
appropri
prior
allergen
challeng
gmcsf
detect
pgml
nal
fluid
obtain
allergen
challeng
subject
allerg
rhiniti
clearli
increas
wilcoxon
sign
rank
test
p
fig
gmcsf
detect
nal
obtain
viru
inocul
subject
could
posit
correl
total
symptom
spearman
correl
coeflici
p
coronaviru
inocul
subject
day
fig
total
symptom
r
p
subject
allerg
rhiniti
gmcsf
level
correl
allergeninduc
rhiniti
symptom
present
studi
demonstr
coronaviru
induc
common
cold
associ
increas
lumin
entri
gmcsf
contrast
allergen
challeng
season
allerg
rhiniti
associ
increas
lumin
entri
gmcsf
increas
knowledg
first
vivo
studi
demonstr
differ
proinflammatori
stimuli
may
induc
product
differ
cytokin
human
nasal
airway
mucosa
lumen
entri
bulk
plasma
occur
common
cold
allergen
challeng
condit
appear
noninjuri
paracellular
process
compromis
integr
epitheli
line
absorpt
barrier
present
sampl
mucos
surfac
materi
although
would
contain
larg
plasma
protein
fibrinogen
inacroglobulin
may
therefor
necessarili
contain
mucos
injuryderiv
factor
absenc
carrier
protein
cytokin
may
readili
pass
biolog
membranesbarri
howev
plasma
protein
high
effici
cytokin
bind
characterist
may
thu
promot
lumen
entri
cytokin
exud
phase
airway
diseas
henc
present
cytokin
may
eman
superfici
cell
lamina
propria
sourc
present
differ
cytokin
profil
viral
infect
allergi
explain
howev
might
consequ
activ
distinct
subset
thelper
cell
sinc
thi
clone
express
mrna
associ
viral
infect
gratifi
abl
record
increas
output
present
studi
clone
express
mrna
gmcsf
found
allerg
inflamm
profil
cytokin
mrna
gmcsf
nasal
mucosa
biopsi
observ
durham
et
al
along
find
cytokin
mrna
profil
lower
airway
support
possibl
activ
type
cell
occur
allergen
challeng
howev
present
studi
could
demonstr
clear
increas
gmcsf
allerg
rhiniti
sinc
employ
differ
subject
popul
exclud
possibl
data
part
reflect
presenc
differ
respond
cell
allerg
nonallerg
nasal
mucosa
studi
examin
effect
cytokin
level
allerg
subject
infect
common
cold
viru
requir
elucid
point
cellular
sourc
present
cytokin
known
product
attribut
activ
cell
natur
killer
cell
addit
recent
studi
dayton
et
al
demonstr
gene
also
express
human
b
cell
ill
may
produc
wide
varieti
cell
also
clear
cell
cell
mast
cell
macrophag
eosinophil
fibroblast
epitheli
cell
may
produc
cytokin
particularli
gmcsf
may
relev
allerg
process
inflammatori
cell
popul
examin
present
studi
allergeninduc
rhiniti
known
accompani
cellular
infiltr
nasal
mucosa
helper
cell
eosinophil
mast
cell
promin
fraenkel
et
al
demonstr
rhinoviru
infect
human
may
increas
infiammatori
cell
nasal
biopsi
thu
sourc
mediat
increas
cellular
airway
mucosa
may
respons
nasal
symptom
common
cold
also
possibl
mucos
endorgan
includ
subepitheli
microcircul
develop
increas
respons
mediat
viral
infect
present
studi
demonstr
correl
level
mucos
surfac
composit
symptom
virusinduc
inflamm
find
suggest
possibl
may
marker
diseas
sever
indic
specif
good
bad
contribut
cytokin
common
cold
process
exert
seri
pleiomorph
effect
immun
cell
myelomonocyt
cell
cell
type
antivir
activ
may
import
function
inde
higgin
et
al
recent
report
intranas
treatment
human
recombin
experiment
rhinovir
infect
healthi
subject
prevent
rhinoviru
infect
ill
contrari
treatment
enhanc
symptom
also
correl
mucos
level
common
cold
symptom
present
studi
fact
better
known
immunomodulatori
antivir
effect
may
suggest
may
import
modul
inflammatori
respons
infect
directli
interf
viral
replic
per
se
furthermor
may
upregul
express
intercellular
adhes
epitheli
endotheli
cell
addit
import
adhes
molecul
inflammatori
cell
also
receptor
rhinovirus
coxsacki
virus
thu
exclud
releas
ill
may
amplifi
spread
infect
inflammatori
respons
common
cold
viral
infectioninduc
product
cytokin
airway
may
serv
promot
inflammatori
respons
inhal
factor
includ
allergen
ida
ei
al
found
viru
incub
caus
enhanc
basophil
activ
peripher
blood
mononuclear
cell
pbmc
contain
basophil
increas
antigenstimul
histamin
releas
evalu
rhinoviru
infect
furthermor
deplet
tcell
pbmc
incub
viru
incub
viruscondit
medium
monoclon
antibodi
lead
inhibit
histamin
releas
activ
suggest
basophil
function
enhanc
substanc
moreov
recombin
shown
promot
eosinophil
surviv
vitro
treatment
viru
condit
medium
monoclon
antibodi
demonstr
inhibit
eosinophil
surviv
enhanc
activ
medium
also
potenti
import
interact
viral
infectioninduc
cytokin
gener
cellular
mechan
allerg
diseas
process
although
role
viral
infect
allergi
asthma
attract
great
interest
inform
interact
mechan
discuss
base
vitro
observ
yet
specul
relev
vivo
situat
suggest
interact
mechan
may
studi
vivo
great
advantag
human
nose
nasal
mucosa
access
vivo
examin
also
potenti
exhibit
mechan
function
may
relev
tracheobronchi
airway
well
conclus
present
result
indic
distinct
cytokin
mechan
express
common
cold
allerg
rhiniti
respect
differ
proinflammatori
stimuli
may
thu
lead
differ
manifest
inflamm
airway
mucosa
cytokin
level
present
vivo
data
cytokin
level
support
view
profil
notabl
agent
present
viral
infect
data
support
view
gmcsf
may
major
cytokin
allerg
airway
diseas
